MAPKAPK3 and glioblastoma: Moreover, we determined the clinical implication of MK3 expression from human GBM and LGG samples in TCGA database, and the significant differences were found in 1p/19q codeletion (Figure 2D), WHO grade (Figure 2E), and IDH status (Figure 2F).